Cite
APA Citation
Radtke, K. K., Hesseling, A. C., Winckler, J. L., Draper, H. R., Solans, B. P., Thee, S., Wiesner, L., van der Laan, L. E., Fourie, B., Nielsen, J., Schaaf, H. S., Savic, R. M., & Garcia-Prats, A. J. (2022). moxifloxacin Pharmacokinetics, Cardiac Safety, and Dosing for the Treatment of Rifampicin-Resistant Tuberculosis in Children. Clinical infectious diseases, 74, 1372–1381. http://access.bl.uk/ark:/81055/vdc_100153815581.0x00002d